In the heart, adrenergic stimulation activates the β-adrenergic receptors coupled to the heterotrimeric stimulatory G s protein, followed by subsequent activation of adenylyl cyclase, elevation of cyclic AMP levels, and protein kinase A (PKA) activation. One of the main targets for PKA modulation is the cardiac L-type Ca 2+ channel (Ca V 1.2) located in the plasma membrane and along the T-tubules, which mediates Ca 2+ entry into cardiomyocytes. β-Adrenergic receptor activation increases the Ca 2+ current via Ca V 1.2 channels and is responsible for the positive ionotropic effect of adrenergic stimulation. Despite decades of research, the molecular mechanism underlying this modulation has not been fully resolved. On the contrary, initial reports of identification of key components in this modulation were later refuted using advanced model systems, especially transgenic animals. Some of the cardinal debated issues include details of specific subunits and residues in Ca leaves no doubt that the β-AR effect is mediated via PKA. [10] [11] [12] [18] [19] [20] [21] [22] Remarkably, the actual molecular mechanism and details of PKA regulation of the channel remain unclear. Many experimental results and proposed mechanisms have not withstood the test of time. Fundamental issues remain unresolved.
C ontraction and relaxation of the heart are regulated by its electric activity. L-Type voltage-dependent Ca 2+ channels (L-VDCC), predominantly of the Ca V 1.2 type, are the main Ca 2+ entry pathway in ventricular cardiomyocytes; L-VDCCs of the Ca V 1.3 type prevail in pacemaker cells and embryonic myocytes. Ca 2+ entry activates the ryanodine receptors (RyR), rapidly elevating Ca 2+ concentration through calcium-induced calcium release, which triggers contraction. Heartbeat is tightly regulated by autonomic and hormonal control. Activation of the sympathetic nervous system, for example, in the fight-or-flight response, increases the heartbeat rate, contractility, and relaxation rate (positive chronotropic, inotropic, and lusitropic effects, respectively). This is caused by catecholamine binding to β-adrenergic receptors (β-AR), which are G-protein-coupled receptors that trigger GDP-GTP exchange at the stimulatory G-protein subunit Gα s . Activated Gα s -GTP separates from Gβγ and activates adenylyl cyclase (AC), resulting in elevated cyclic AMP (cAMP) levels and activation of the cAMP-dependent protein kinase (protein kinase A [PKA]), which phosphorylates multiple target protein, among them L-VDCC, troponin I, and phospholamban.
Mammalian cardiomyocytes express 3 β-AR subtypes, β1-to β3-AR, primarily the β1-AR (≈80%) and substantially β2-AR 5 . β1-AR is coupled exclusively to Gα S , whereas β2-AR is coupled to both G s and the inhibitory G i/o 6 . Activity of β1-AR, located at the plasma membrane, produces elevation in cAMP throughout the cell, whereas β2-AR produces spatially restricted cAMP increase, probably close to the T-tubules. [7] [8] [9] Increased Ca 2+ entry into the myocytes via the cardiac Ca V 1.2, mediated by both β1-and β2-AR, [10] [11] [12] [13] substantially contributes to the positive inotropic effect of β-AR activation ( Figure 1 ). This process is central to normal cardiac physiology and is involved in pathophysiological changes occurring in cardiac hypertrophy and heart failure. 5, 13, 14 Detailed characterization of the β-AR-activated, PKA-mediated regulation of L-VDCC is, therefore, crucial for understanding normal and pathological cardiac physiology. Moreover, neuronal Ca V 1.2 is regulated by PKA similarly to cardiac Ca V 1.2, although isoform-specific or regulatory protein-specific details may vary.
In particular, major controversies arose from the attempts to reproduce the physiological observations in heterologous expression systems, which is crucial for detailed studies of molecular mechanisms of ion channel regulation. Recent studies in transgenic mice [23] [24] [25] [26] rejected accepted schemes that prevailed a decade ago and presented in prominent reviews. 18, 21, 22 Some of the disputed findings and mechanisms are summarized in Table 1 and will be referred to throughout the article. This review focuses on achievements and controversies in our understanding of β-AR-PKA regulation of cardiac Ca V 1.2 and attempts to sort out the unresolved issues and to suggest directions for further research.
L-Type Calcium Channel
L-VDCCs (Ca V 1.1-Ca V 1.4) play critical roles in excitationcontraction coupling in cardiac, skeletal, and smooth muscle, regulate Ca 2+ homeostasis, secretion, tissue development, excitability, and excitation-transcription coupling, and are involved in learning and memory in the brain. 10 ,27-33 L-VDCCs are multisubunit proteins containing, as a minimum, α 1 (the pore-forming subunit) and the auxiliary Ca V β and α 2 δ subunits. α 1 is composed of 4 homologous transmembrane domains and cytoplasmic N terminus (NT) and C terminus (CT). The CACNA1C gene encodes the α 1 subunit of Ca V 1.2, α 1C , which is expressed in cardiac and smooth muscle and in the brain; multiple isoforms are present because of alternative splicing. 28, 34, 35 Furthermore, post-translational proteolytic cleavage of α 1C yields a dCT-truncated α 1C form of ≈210 kDa, which in most cases can be detected along with a full-length ≈240-kDa protein. [36] [37] [38] [39] [40] [41] The site of proteolytic cleavage in the homologous α 1S of the skeletal muscle, Ala1664, has been determined with high precision. 40 The corresponding residue in α 1C of the cardiac Ca V 1.2 is Ala1800 42 (Figure 2 ), predicting a ≈35-kDa cleaved dCT polypeptide. The cleaved dCT seems to remain associated with the main α 1C , tonically inhibiting it. [38] [39] [40] 43, 44 The Ca V β subunit binds with high affinity to an α 1 interaction domain in loop 1 (Figure 2 ), 45 and it is profoundly important for VDCC biogenesis and regulation. It elevates macroscopic Ca 2+ current (I Ca ) by increasing surface density of α 1 and the open probability (P o ), regulates inactivation, and enhances activation by shifting the current-voltage curve (I-V curve) to hyperpolarized voltages. [48] [49] [50] [51] A similar modal shift also occurs after activation of Ca-/calmodulin-dependent kinase II (CaMKII), 52 coexpression of the Ca V β subunit, 53 and during voltage-dependent facilitation (VDF) after strong depolarization 54 (see below). The mechanistic and structural basis of phenomenologically similar changes in gating, caused by diverse regulatory agents, is not known and presents a fascinating challenge for future research. β-AR stimulation and PKA also increase channels' sensitivity to depolarization, as reflected in a hyperpolarizing shift in the I-V curve. 18, 55 In addition, β-adrenergic modulation of Ca V 124 and several other amino acid residues which are mentioned in the text. All numbering is according to the rabbit α 1C , the first cDNA of an α 1C cloned 69 (GenBank accession number X15539). In the names of protein domains (EF hand and IQ domain), capital letters refer to amino acids glutamate (E), phenylalanine (F), isoleucine (I) and glutamine (Q). AID indicates α 1 interaction domain.
3. The target protein should be a substrate for PKA-CS, and dephosphorylated by a protein phosphatase. 4. The requirement for inhibition of the physiological response (in our case, increase in I Ca ) by specific PKA inhibitors is becoming consistently imposed. 5. Putative PKA phosphorylation sites should be identified in the primary protein sequence and confirmed using biochemical methods. 6. The reconstitution criterion: to confirm that the putative phosphorylation sites (and any auxiliary proteins) are physiologically relevant, the β-AR/cAMP/PKA regulation of the target protein should be reconstituted in a heterologous model cell system when all the participating proteins are expressed. Elimination of phosphorylation site(s) in the protein by mutagenesis should abolish modulation by PKA.
For many physiological regulations, the role of phosphorylation has been established by fulfilling most or all of the above criteria. However, in the specific case of Ca V 1.2, criterion 6 turned out to be difficult to fulfill and the results proved controversial. Therefore, recent studies have been using an additional, particularly rigorous criterion: 7. Transgenic animals or manipulated native cells expressing the target protein lacking putative phosphorylation sites (or auxiliary proteins proposed to be crucial for the regulation) should not exhibit the physiological response to PKA and adrenergic stimulation.
These guidelines are by no means stiff or obligatory and are presented to simplify the reading of this review and, potentially, to provide a flexible framework to guide future studies.
The Classical Period: β-AR Regulation of L-Type VDCC is Mediated by PKA
PKA is a tetramer of 2 regulatory (PKA-R) and 2 catalytic subunits. When inactive, the regulatory and catalytic subunits are bound, and on cAMP addition PKA-R binds cAMP and PKA-CS is released 59 .
Early works, corroborated by many recent studies, found a β-AR-induced activation of AC followed by a rise in cAMP in the heart and in cultured cardiomyocytes, showed enhancement of L-VDCC currents in cardiomyocytes by cAMP, PKA-CS, phosphodiesterase, and protein phosphatase inhibitors, and demonstrated negation of these effects by protein phosphatases 12, 18, 21, 60, 61 . Purified PKA-CS has been shown to activate purified Ca V 1.1 (the L-VDCC of the skeletal muscle) and cardiac Ca V 1.2, after reconstitution in lipid bilayers and liposomes [62] [63] [64] [65] [66] suggesting that the target for PKA regulation is the channel itself. These studies satisfied criteria 1 and 2 listed above.
Both α 1C and β Subunits are Phosphorylated by PKA
Once Ca V 1.2 subunits were cloned and splice variants analyzed, 35 several putative PKA phosphorylation sites have been identified in α 1C and Ca V β subunits. Initial studies did not observe PKA phosphorylation of α 1C in membranes of cardiomyocytes or after partial purification of the protein. 67, 68 However, in 1996, Ser1928 (numbering by rabbit α 1C ) 69 was identified as the main PKA site in α 1C . Ser1928 was found to be the only site phosphorylated by PKA in vitro in rabbit heart α 1C using site-specific antibodies 38 and by monitoring direct PKA phosphorylation of α 1C expressed and purified from Saccharomyces cerevisiae. 70 Finally, phosphorylation of Ser1928, in the full-length α 1C only, in response to β-AR stimulation was confirmed in vivo in intact cardiomyocytes using site-specific antibodies. 38, 71, 72 Moreover, studies that used biochemical and recombinant DNA methods also identified Ser1928 as a strong substrate for PKC, 73 for cGMP-dependent protein kinase, 74 and also for protein kinase D (formerly called PKCµ). 75 Recently, Emrick et al 76 identified Ser1575 and Thr1579 of Ca V 1.1 (α 1S ) as in vitro and in vivo targets for PKA in the skeletal muscle and then demonstrated the phosphorylation of the homologous Ser1700 and Thr1704 in cardiac α 1C 42 ( Figure 2 ). Ca V β 2 is phosphorylated both in vitro by PKA-CS on Ser459, Ser478, Ser479, and Ser296 (numbering by rabbit β 2b ) and in vivo after adrenergic stimulation. [77] [78] [79] [80] In summary, these studies satisfied criteria 3 and 5: α 1C and β subunits of Ca V 1.2 are PKA targets; the functional importance of the various phosphorylation sites is discussed below.
PKA Inhibitors and β-AR Regulation
The use of protein kinase inhibitors (criterion 4 above) is both an essential step and a potent diagnostic tool in establishing the involvement of a protein kinase in a biological regulation. In principle, the functional effect of a kinase can be mediated either by phosphorylation of the target protein or by a direct interaction with it. A phosphorylation mechanism can be strongly supported by the use of inhibitors acting at the active (catalytic) site of the kinase. In comparison, inhibitors of kinase activation, for example, cAMP analogs such as adenosine-3',5'-cyclic phosphorothioate (Rp-cAMPS), which prevent dissociation of PKA subunits, cannot discriminate between the 2 mechanisms. Unfortunately, most synthetic inhibitors acting at the evolutionary conserved catalytic site, such as the widely used H-89, are not entirely PKA specific. 81 For PKA, a widely used choice is the highly specific protein inhibitor initially purified from rabbit skeletal muscle and heart, 82, 83 termed heat-stable cAMP-dependent protein kinase inhibitor, or heat-stable PKA-inhibiting protein (PKI). PKI and PKI-derived peptides not only inhibit the catalytic activity of PKA by interacting with the PKA-CS but also suppress the dissociation of PKA-CS from PKA-R. 84, 85 The K i of PKI for PKA-CS is ≈0.5 to 5 nmol/L 86 . However, proteolysis of PKI and PKI-derived peptides in living cells is common. Also, in functional studies, the inhibitor's final concentration within the cell and in the channel's microenvironment is difficult to estimate. This often serves an excuse for using high doses of inhibitors to obtain positive results (inhibition of physiological regulation). Such results must be interpreted with caution because of limited specificity of most inhibitors. Moreover, in view of batch variability and potential loss of potency of many compounds in transportation and storage, negative results (absence of a compound's effect) need to be verified by demonstrating an effect of the same batch of the compound on an established target.
The β-AR-induced increase in I Ca is highly sensitive to PKA inhibitors. Direct intracellular perfusion (dialysis) of the myocytes through the patch pipette often yielded incomplete inhibition of the β-AR effect: 50% to 70% with 1 µmol/L PKI, 0.5 mmol/L Rp-cAMPS, or a cocktail of PKA and phosphorylation inhibitors. [87] [88] [89] [90] Other works reported full inhibition of effects of β-AR agonists in frog and rat ventricular cardiomyocytes by dialyzing cells with 2 to 5 mmol/L Rp-cAMPS, 16 µmol/L PKI (which is >3 orders of magnitude higher than its K i ), 20 µmol/L PKI peptide (PKI [15] [16] [17] [18] [19] [20] [21] [22] ; K i =36 nmol/L), [91] [92] [93] or with 1 µmol/L H-89 applied externally. 94 Although the latter studies used rather high doses of inhibitors, the accumulated data strongly support the view that a major part and possibly all of the β-AR enhancement of cardiac Ca V 1.2 is mediated by activation of PKA.
Nevertheless, initial reports of a residual β-AR enhancement of I Ca in the presence of PKA inhibitors prompted a search for additional mechanisms. Yatani et al 95, 96 and Pelzer et al 97 reported a PKI-resistant enhancement of Ca V 1.2 activity in excised patches of cardiomyocytes by the nonhydrolyzable GTP analog GTPγS and by GTPγS-activated Gα s . Yatani and Brown 98 proposed that a fast phase of the β-AR regulation of L-type Ca 2+ channels is mediated by a direct, membranedelimited effect of Gα s , whereas a slow phase is mediated by the PKA phosphorylation. In contrast, using a fast perfusion system, Hartzell et al 91 and Méry et al 99 observed a monophasic slow isoproterenol (Iso) effect which was fully blocked by PKA inhibitors, both in frog and mammalian cardiomyocytes, and refuted the idea of any physiological role for direct regulation of cardiac Ca V 1.2 by Gα s . These conclusions have been supported later by kinetic measurements with fast cAMP sensors. 100 Some of the results obtained in excised patches or in perfused cells that seemed to support the direct effect of G proteins could be because of a partial relief of Mg 2+ inhibition 101 or of channel rundown in ATP-free solutions used. 60, 102 to propose the hypothesis, which became quite popular and was supported by studies in other cell types 103 that the L-VDCC needs to be basally phosphorylated by PKA to become functional. However, smaller or no effects on basal I Ca were seen in later works that used cell dialysis of inhibitors through the patch pipette or extracellular incubation with cell-permeable inhibitors. The results are divergent, from no effect of Rp-cAMPS (0.1-2 mmol/L in the pipette) and H-89 in adult mouse cardiomyocytes, 92, 104, 105 through a minor ≈20% reduction in basal I Ca by dialysis of purified PKI protein (2.9 µmol/L) in adult guinea pig myocytes, 88 to 20% to 55% inhibition in late versus early embryonic mouse cardiomyocytes, respectively, after extracellular application of 15 µmol/L of a cell-permeable PKI peptide. 72 Interestingly, reduction in basal I Ca caused by PKA inhibitors 72 or protein phosphatase PP2A 106 was correlated with a decrease in phosphorylation of Ser1928, monitored with a site-specific antibody. 72, 106 In myocytes of atrium and sinoatrial node PKA inhibitors reduced basal I Ca by 25% to 36%, 107, 108 but the contribution of Ca V 1.3 cannot be excluded. In all, the accumulated evidence suggests a minor role for PKA in the maintenance of basal I Ca in healthy adult ventricular cardiomyocytes.
And yet, basal I Ca is strongly enhanced by phosphatase inhibitors. 61 Therefore, phosphorylation must play a role unless phosphatases regulate the channel exclusively by direct interactions. Unlike the effect of Iso, the enhancement of basal I Ca by phosphatase inhibitors is not blocked by PKA inhibitors. 92 ; however, a PKC inhibitory peptide was without effect. 92 In all, basal I Ca in mammalian cardiomyocytes is regulated by a balanced action of serine/threonine kinases and phosphatases 104, 106, 113 ; the kinases involved remain to be identified. Notably, phosphorylation and dephosphorylation also regulate the level of the membrane phosphatidyl inositol biphosphate, a ubiquitous regulator of ion channels and transporters. 114 Phosphatidyl inositol biphosphate is involved in the maintenance of the basal I Ca of some VDCCs, [115] [116] [117] and its role in cardiac Ca V 1.2 awaits further study.
Rundown
Regulation of basal I Ca of L-VDCCs by PKA has been initially linked to the phenomenon of rundown-a decrease in channel activity with time during recording in dialyzed cells and in particular in excised patches. Rundown is not observed in cell-attached patches or sharp-electrode recordings that do not involve dilution of cell interior, indicating that nonmembrane ingredients are involved. 101 Channel proteolysis and (de)phosphorylation have been the most widely proposed potential mechanisms. ATP slows the rundown, but the nonhydrolyzable ATPγS does not prevent rundown; therefore, dephosphorylation cannot be the only cause. 101 Initially, cAMP and PKA-CS were reported to reverse rundown of L-VDCCs in cardiomyocytes and other cells. 103, 118, 119 However, some of these results could be because of PKA-induced activation of Ca V 1.2 by a mechanism unrelated to the rundown. Later works showed that rundown can be reversed by cytosolic extracts from cardiomyocytes and other cells. Calpastatin (an endogenous inhibitor of the protease calpain) together with additional high molecular weight cytosolic factors 120, 121 or the addition of calmodulin together with ATP has been reported to prevent the rundown of Ca V 1.2 110, 122, 123 (calmodulin is VDCC regulator, which is constitutively associated with Ca V 1.2 and tightly regulates its function both directly and via CaMKII). 124 A recent study in neurons demonstrated Ca
2+
-dependent rundown of Ca V 1.2 through endocytosis mediated largely by Ca-/ calmodulin-induced displacement of α-actinin. 125 It seems that the rundown is not the opposite of the regular basal I Ca but the result of a collapse of the multiprotein complex within which the channel operates and of the phosphorylation-dephosphorylation balance of the channel or associated proteins.
Reconstitution of PKA Regulation in Heterologous Models and Rigorous Tests of Proposed Mechanisms in Transgenic Animals
Proteolytic Cleavage of dCT of α 1C
The dCT seems to be a critical structural element in PKA regulation. Transgenic mice expressing α 1C truncated at amino acid (a.a.). 1820 or 1905 (rabbit α 1C count) died at birth; embryonic cardiomyocytes showed a greatly reduced I Ca (probably because of enhanced Ca V 1.2 degradation), heart hypertrophy, and loss of β-AR regulation of the remaining small I Ca . 126, 127 Although the latter result supports a role for dCT in β-AR regulation, it is uncertain whether other β-adrenergic regulations and vital functions were not disrupted in these defective hearts.
dCT also serves as a transcription factor that migrates to the nucleus and autoregulates the expression of α 1C in neurons, cardiomyocytes, and smooth muscle. 41, 128, 129 In heart and smooth muscle, the dCT reduces the expression of α 1C . 41, 129 In the heart, blockage of Ca V 1.2 results in a dCT-dependent protein upregulation which is regulated by cytoplasmic Ca 2+ concentrations. [129] [130] [131] [132] Heterologous expression in nonexcitable cells normally yields only the full-length, and completely functional, α 1C protein. 44, [133] [134] [135] [136] However, in some works, both full-length and truncated α 1C can be seen in transfected human embryonic kidney (HEK) cells. 41, 128 Removal (by mutagenesis) of the dCT from heterologously expressed α 1C increases current amplitude, 137, 138 and coexpression of the dCT as a separate peptide reverses this effect and reduces I Ca . Removal of dCT affects Ca V 1.2 gating similarly to PKA: it causes a hyperpolarizing shift in the I-V curve and increases its P o . 43, 44, 137, 139 Accordingly, it has been proposed that the dCT folds over another part of the channel to inhibit activity, and that phosphorylation by PKA may relieve this inhibition. 136, 137, 140, 141 Recently and more specifically, the inhibitory effect of the dCT regulatory domain (DCRD) has been attributed to the formation of a stoichiometric noncovalent complex with the proximal part of the CT 43, 44 at the proximal C-terminal regulatory domain. 44 An initial study mapped the DCRD to a.a. 2024 to 2171 and proximal C-terminal regulatory domain to a.a. 1733 to 1900 43 . However, later studies that combined ab initio modeling, mutagenesis and protein interaction measurements suggested a different location of DCRD, between a.a. 2062 and 2115. Two positively charged arginines at positions 1696 and 1697 in the proximal C-terminal regulatory domain were found crucial for interaction with the DCRD. 44 A recent study suggests a dynamic model for dCT inhibition of α 1C ; as intracellular Ca 2+ concentration increases, the inhibitory effect of the cleaved dCT diminishes, thus allowing for greater calcium entry during systole. 132 The percentage of total α 1C that is cleaved in native cardiomyocytes is an unresolved dispute. Estimates vary from almost none to full truncation ( Table 2 ). Such variability may arise from differences in species, ages, experimental conditions, and some regulatory control of truncation; however, investigators 15, 36, 38 also warned against nonspecific proteolysis during tissue preparation. With optimized extracting procedures, ≈50% of Ca V 1.2 in cardiomyocytes were found nontruncated. 15 Thus, Ca V 1.2 channels containing the fulllength α 1C seem quite abundant in the heart. Despite its insensitivity to PKA in heterologous expression systems (see below), the question whether the full-length α 1C is regulated by the β-adrenergic cascade in real cardiomyocytes remains unresolved.
Given the physiological importance of the dCT and the emerging evidence that full-length and truncated α 1C coexist in cardiomyocytes, the proteolytic cleavage of α 1C is probably tightly regulated. This is mostly unexplored. In the brain, proteolysis seems to be regulated by Ca 2+ influx via the NMDA channels that activate the Ca 2+ -dependent protease calpain. 15, 142 The protease that cleaves α 1C in the heart has not been identified, although it is assumed to be calpain like. 101, 121, 143 It is important to see whether dCT cleavage in the heart is also a Ca 2+ -dependent process; identification of the cardiac-specific protease and its regulation is vital.
Basal I Ca in the Absence of PKA Activators
In the majority of popular heterologous expression systems, even when no positive PKA regulation of Ca V 1.2 was reported, introduction of PKI and less specific inhibitors or protein phosphatases usually reduced I Ca . 42, [144] [145] [146] In Xenopus oocytes, Rp-cAMPS and H-89 reduced basal I Ca by 20% to 30%, mutating Ser1928 to Ala reduced basal I Ca and abolished the regulation by PKA inhibitors. 147 Similarly, Ser1928 , Figure 7 41 Rat and human cerebral arteries ≈30% truncated 41 , Figure 1B dCT indicates distal C terminus.
sustained basal I Ca in heterologously expressed human α 1C in HEK cells. 75 Disruption of AKAP-PKA interaction by a specific peptide, Ht-31, reduced basal I Ca of Ca V 1.2 expressed in HEK cells, suggesting a role for an unidentified endogenous AKAP. Notably, this effect of Ht-31 was absent when Ser1928 was mutated to Ala. 148 Thus, it seems that phosphorylation of Ser1928 by one or several kinases, maybe in conjunction with an AKAP regulation, plays a role in sustaining basal I Ca of fulllength α 1C in heterologous systems. Also, phosphorylation of Thr1704 has been implicated in basal I Ca in HEK cells. 42 The physiological relevance of these findings is unclear because the role of PKA in basal I Ca may be different in cardiomyocytes. The option that phosphorylation of Ser1928 may be related to the basal regulation by other protein kinases has not been studied sufficiently.
Reconstitution of the VDF of Ca V 1.2
Ca 2+ entry during an action potential or a depolarizing pulse induces Ca
2+
-dependent inactivation of L-VDCCs. 149 In cardiomyocytes, there is also an opposite process referred to as facilitation or positive staircase, whereby the amplitude of Ca 2+ current increases in a manner dependent on stimulus strength and frequency. 150, 151 Facilitation is believed to contribute to the increase in Ca 2+ influx during increased cardiac work, and probably comprises several components. One component is a Ca 2+ -dependent facilitation, which involves CaM and, at least it part, CaMKII. 124, 153, 154 A second, Ca
-independent mechanism, called VDF, takes place when either Ba 2+ or Ca 2+ carry the current. In VDF, the current is enhanced after strong depolarizing prepulses because of a shift to mode 2 gating. 54, 155 VDF in neuronal (Ca V 2) channels is mainly because of depolarization-induced dissociation of G-protein Gβγ subunits from the α 1 subunit of the channel (reviewed in Dolphin et al 156 and Tedford et al 157 ). However, the mechanism of VDF of Ca V 1.2 is not well understood and does not seem to involve interaction with G-protein subunits. 158 Sculptoreanu et al reported the reconstitution of Ca V 1.2 VDF in a CHO-derived CCAR3217 cell line expressing the full-length α 1C without α 2 δ or Ca V β. VDF required active PKA, was abolished by PKI and was occluded by long exposures to PKA. The authors proposed that VDF is fully dependent on a voltage-regulated PKA phosphorylation and dephosphorylation of α 1C . Reconstitution of VDF in heterologously expressed Ca V 1.2 was confirmed by other groups; however, the results and conclusions were often controversial. In Xenopus oocytes, depolarizing prepulses increased I Ba ≤3-fold with no need for cAMP or PKA injection; this effect was partially blocked by H-7 (a broad protein kinase inhibitor), PKI, and Rp-cAMPs and unaffected by cAMP or PKA-CS 159 . Bourinet et al 159 proposed that only PKA-phosphorylated channels are subject to VDF rather than PKA phosphorylation is voltagedependent. Dai et al 160 reconstituted VDF in HEK cells and conclusively demonstrated that, in this preparation, it is not affected by the presence or block of PKA or by the addition of AKAP5 and equally occurs with either full-length or dCTtruncated α 1C . Somewhat paradoxically, VDF was inhibited by the α 2 δ subunit 160 rendering the physiological relevance of the reconstituted VDF less certain. Interestingly, VDF reconstituted in oocytes and HEK cells crucially depended on coexpression of the Ca V β subunit, 18, 159, 161 although a weak, PKA-, PKI-, and G-protein-independent VDF was reported in CHO cells expressing the smooth muscle α 1C alone. 162 In all, the bulk of reported results support a major role for the Ca V β subunit in the VDF of Ca V 1.2 reconstituted in heterologous systems. The reliance of VDF on Ca V β subunit, its independence of dCT and AKAPs, and insensitivity to PKA blockers does not support a crucial role for PKA. The exact molecular mechanism of VDF in Ca V 1.2 awaits further study.
Regulation by PKA Activators or PKA-CS
Numerous unsuccessful attempts were made during the past 2 decades to reconstitute the complete β-AR-induced regulation of L-VDCC (beginning with the application of an agonist) using heterologously expressed cloned (cDNA derived) receptors, channels, and other proteins of the signaling cascade. However, there are several reports of regulation of cloned Ca V 1.2 by the AC activator forskolin, cAMP or its analogs, or PKA-CS. The results are diverse, depicting various sites on different subunits of the channel as being crucial for regulation of Ca V 1.2 by PKA phosphorylation (Table 1 ).
In the majority of studies, the heterologously expressed fulllength α 1C , with or without coexpressed β and α 2 δ subunits, was not regulated by PKA-CS or PKA activators. 42, 144, 145, 163, 164 It has been initially proposed that the expressed Ca V 1.2 is fully phosphorylated which explains why PKA cannot augment I Ca , whereas inhibition of PKA or dephosphorylation by added phosphatases can reduce basal I Ca . 144, 145 In a 1995 review, Charnet et al 165 presented a summary of reconstitution attempts in Xenopus oocytes, CHO, and HEK cells. They particularly emphasized that, in contrast to channels expressed from separate Ca V 1.2 subunit gene products, I Ca was enhanced 1.5-to 3-fold by β-AR stimulation when total cardiac RNA was injected into oocytes. 166 , 167 Charnet et al 165 proposed that an additional protein(s) (missing link) may be needed for the full reconstitution of the PKA effect.
Despite the above, several groups have reported reconstitution of PKA regulation in heterologous systems expressing full-length α 1C (Table 1) . A particular CHO-derived cell line constitutively expressing full-length α 1C alone (CCAR3217) was used in 2 studies, which reported a large enhancement of I Ca (>3-fold) by cAMP, dibutyryl-cAMP, and PKA-CS. 168, 169 Interestingly, 2 molecular sizes of the expressed α 1C were observed, suggesting α 1C cleavage or truncation in these cells. Activation of PKA increased phosphorylation of the full-length α 1C (250 kDa) but not of the truncated form (200 kDa). 169 The presence of endogenous auxiliary VDCC subunits or AKAPs in this cell line has not been characterized. In a baby hamster kidney (BHK6) cell line stably expressing Ca V β and α 2 δ, and transiently expressing α 1C , forskolin enhanced I Ca . 170 The enhancement was blocked by PKI and by mutating Ser1928, although the forskolin-induced shift in the I-V curve persisted in the Ser1928Ala mutant. 170 No data are available on the possible proteolytic cleavage of α 1C in this system. In all, a spontaneous cleavage of the dCT and possibly the presence of endogenous AKAPs or other missing link proteins may have assisted the reconstitution of the PKA effect in these studies. As summarized in Table 1 , the discrepancies between these and other works have never been resolved.
An influential and widely cited study reported the reconstitution of PKA regulation of Ca V 1.2 containing the full-length α 1C coexpressed with AKAP5 in HEK cells. 164 PKA activation by forskolin or a cAMP analog increased channel phosphorylation and caused a 50% increase in I Ca and a shift in I-V curve (however, ≈50% of the cells were irresponsive). This regulation was absent in the Ser1928Ala mutant of α 1C or when AKAP5 was not coexpressed. 164 In a follow-up study in HEK cells, Bünemann et al 77 reported a 2-fold PKA-CS-induced increase in I Ca of α 1C truncated at a.a. 1905 (α 1C Δ1905) , missing both the Ser1928 and the DCRD. The regulation did not require AKAP but crucially depended on the presence of intact Ca V β 2a and was abolished by double mutation of the strong PKA phosphorylation sites in Ca V β, Ser478, and Ser479. The authors proposed that the phosphorylation of Ca V β on these serines underlies most of the PKA-induced enhancement in I Ca amplitude, whereas the AKAP-dependent phosphorylation of Ser1928 in α 1C mediates some of the increase in I Ca and the shift in the I-V curve. 77 In contrast, subsequent studies were unsuccessful in reproducing the robust PKA-induced regulation of either full-length or dCT-truncated α 1C , even in the presence of AKAPs, in HEK cells or Xenopus oocytes. At best, small increases (15%-20%) in I Ca were observed 42, 160, 171, 172 (and our unpublished results). Despite these reservations, the 2 studies 77, 164 have led to a prevailing concept of a molecular mechanism in which PKA, anchored at the CT of α 1C via an AKAP, regulates Ca V 1.2 by phosphorylating Ser1928 in α 1C and 2 serines in Ca V β after activation by cAMP 18, 21 . Recent studies in cardiomyocytes refuted the role of Ser1928 and phosphorylation of the β subunit but confirmed the necessity of the dCT (Table 1 ). In the first study, 173 adult cardiomyocytes were virally transfected with a mutated Ca V β 2a subunit lacking 2 prominent phosphorylation sites and 3 distinct GFPlabeled constructs of a dihydropyridine-insensitive α 1C : wild type (WT), a Ser1928Ala mutant, and the α 1C Δ1905-truncated channel. The Iso-induced increase in I Ca was abolished in the Δ1905-α 1C but persisted in Ser1928Ala-α 1C suggesting that the dCT was essential for Iso-induced activation, but phosphorylation of Ser1928 was not. 173 Notably, the Iso-induced increase in I Ca was ≈50%, substantially smaller than the >3 fold increase of the endogenous I Ca recorded in the same cells. This difference could be because of overexpression of the Ca V β subunit 171 or the use of Ca V β 2a instead of Ca V β 2b , which is the dominant Ca V β in the heart.
A second study 23 analyzed the role of Ser1928 in vivo using transgenic mice with a knockin mutation of Ser1928Ala. β-AR regulation of heart rate and contraction, I Ca density, and the I-V relationship, as well as Iso-or forskolin-mediated 2.5-to 3-fold increase in I Ca were indistinguishable from the WT mice. Protein levels of β1-AR and PKA subunits, as well as their coimmunoprecipitation with Ca V 1.2 (indicating the correct formation of the signaling complex), were also intact. Noteworthy, Western blots showed only a full-length 250-kDa α 1C , in both WT and Ser1928Ala mice. 23 This raises the interesting question whether the full-length α 1C was the isoform involved in the β-AR regulation in these mice.
The crucial role of phosphorylation of Ca V β in PKA regulation was also overturned by recent studies using transgenic mice and transfected cardiomyocytes. First, PKA-induced enhancement of I Ca was preserved in cardiomyocytes infected with a Ca V β 2 lacking the crucial phosphorylation sites Ser459, Ser478, and Ser479 171, 173 . Second, transgenic mice with Ca V β 2 truncated to remove PKA phosphorylation sites Ser478 and Ser479 (according to rabbit β 2b count) demonstrated an unaltered β-adrenergic stimulation of cardiomyocytes by Iso. 26 Finally, the effect of Iso in mice lacking both Ser1928 in α 1C and the 2 strong phosphorylation sites of Ca V β 2b was the same as in the WT mice. 26 These results strongly suggest that PKA phosphorylation of neither Ser1928 in α 1C nor the prominent serines478 and 479 in Ca V β 2 are essential for the Iso-induced enhancement of I Ca .
The confusion from all of the data collected is rather overwhelming (Table 1) . A recent seminal study by Fuller et al 42 may help resolve the conundrum. They reconstituted PKA modulation in tsA cells (an HEK-derived cell line) by expressing a complex of a dCT-truncated α 1C , the dCT as a separate polypeptide, α 2 δ, Ca V β, and AKAP7. I Ca of α 1C Δ1800 (truncated at a.a. 1800) was not enhanced by activated PKA irrespective of AKAP expression. In contrast, when α 1C Δ1800 was expressed together with the separate dCT, I Ca was increased and Ser1700 became phosphorylated by forskolin-activated PKA, as well as by Ca 2+ -activated CaMKII. The functional regulation of I Ca required coexpression of AKAP7 in a precisely titrated range while avoiding overexpression. Analysis of phosphorylation site mutants indicated that Ser1700 and Thr1704 participate in sustaining basal I Ca , whereas Ser1700 is the site underlying the PKA-induced current enhancement. Activation of PKA increased the phosphorylation of Ser1928 in full-length α 1C , but failed to enhance I Ca .
42 Ser1700 and Thr1704 are located in the proximal CT, proximally to the proteolytic cleavage site, at the interface between the proximal C-terminal regulatory domain and the DCRD. 44 Thus, this site may be occluded when α 1C is not truncated explaining the failure to observe its phosphorylation in full-length α 1C . Fuller et al 42 hypothesized that the molecular mechanism of PKA regulation of Ca V 1.2 involves phosphorylation of Ser1700 by AKAP-anchored PKA, which promotes the dissociation of the cleaved dCT and removes its autoinhibitory effects, thus increasing I Ca (as noted below, AKAP7 knockout mice retain the β-adrenergic response, possibly because of compensation by other AKAPs).
Despite these new and inspiring insights, several unsettled issues, related to heterologous reconstitution, deserve attention. One is the role of PKA in basal I Ca . In the best reconstitution setting (α 1C Δ1800 coexpressed with dCT and AKAP7), the reduction of basal I Ca was ≈30% with 1 µmol/L PKI [14] [15] [16] [17] [18] [19] [20] [21] [22] peptide and ≈50% with a mixture of higher concentrations of 2 PKI peptides. Such sensitivity to blockers resembles embryonic cardiomyocytes or other heterologous expression studies but is somewhat higher than in adult cardiomyocytes. Furthermore, forskolin increased the basal I Ca by <2-fold, still less than in cardiomyocytes, although if compared with the current level after PKA inhibition, the calculated overall range of regulation was ≈360%. 42 It seems that a component of PKAinduced increase is missing, or the basal phosphorylation level is too high. It is possible that a participant of the signaling complex, maybe a phosphatase, is still missing. Another problem is the use of a high concentration of the potent PKC inhibitor, Ro 31-8220, to assay some of the PKA effects. The K i of Ro 31-8220 for PKCα inhibition is 33 nmol/L; at 1 µmol/L, PKCα is inhibited by 97% and PKA by 70% in vitro. 81 The concentration of 1 µmol/L of Ro 31-8220 was used in most experiments (eg, when directly probing the phosphorylation sites using site-specific antibodies and for the assessment of the role of the phosphorylation sites regulating the basal I Ca ). 42 Although 50 nmol/L Ro 31-8220 had almost no effect on I Ca , with 1 µmol/L of this blocker one may expect a more robust inhibition of various PKC isoforms. PKC may play a role in basal I Ca (see above) and PKC activation increases I Ca 21 with a possible involvement of Ser1928 174 ; therefore, its role in some of the effects of Ro 31-8220 on basal I Ca cannot be excluded.
Requirement for AKAPs and Other Auxiliary Proteins in the β-Adrenergic Modulation of α 1C
cAMP/PKA compartments, or microdomains, are important in β-AR signaling. 175 Microdomains may form in caveolae or membrane rafts, or within multiprotein complexes held together by scaffold proteins. [176] [177] [178] AKAPs specifically tether the PKA-R dimers to a PKA substrate or microdomain, but they also act as scaffolds supporting multiple protein-protein interactions. The function of such complexes is controlled by many factors and includes feedback mechanisms achieved by phosphodiesterases, protein phosphatases, and additional factors. [179] [180] [181] The AKAP-PKA complex is attached to α 1C , which is considered to be the core of the signaling complex, via the dCT. 16, 178, 182 AKAP5 directly interacts with the CT and additional cytosolic segments of the α 1C subunit of Ca V 1.2 in neurons. 183 AKAP7 interacts with Ca V 1.2 via leucine zipper-like motif within the dCT (a.a. 2057-2115). 182, 184 Disruption of AKAP-PKA interactions with specific peptides inhibits PKA regulation of Ca V 1.2 in neurons, smooth muscle, and cardiomyocytes. 148, 164, 182, 185 The reduced β-AR modulation of cardiomyocytes from Ca V 1.2 dCT −/− transgenic mice (CT truncated at a.a. 1796) was correlated with reduced surface expression of Ca V 1.2 and localization of AKAP7 127 . Reconstitution of cAMP-PKA activation and L-VDCC modulation in heterologous expression systems seems to require AKAPs. 42, 164 These finding strongly suggested a crucial role of AKAPs, in particular AKAP5 and AKAP7, in PKA regulation of Ca V 1.2. Yet again, recent studies with transgenic mice do not clearly support this notion.
First, knockout of AKAP5 did not abolish the β-AR regulation of Ca V 1.2 25 . In fact, I Ca was increased by Iso or forskolin to the same extent in cardiomyocytes from WT or AKAP5 −/− mice. However, calcium transients, which report the release of Ca 2+ from the sarcoplasmic reticulum (SR) via RyR 2 , were not responsive to β-AR activation in the AKAP5 −/− mice. This was probably because of the disruption of the AKAP5-containing signaling complex which comprises, in addition to AKAP, AC 5/6, PKA, protein phosphatase 2B, Ca V 1.2, and β-ARs. This complex generates a microdomain of cAMP that is juxtaposed to the RyR 2 thus affecting the amplitude and duration of calcium transients. 25 Interestingly, the authors observed that in wild-type myocytes, only Ca V 1.2 channels associated with caveolin-3 were phosphorylated by PKA (on Ser1928, as shown with a site-specific antibody) after β 1 -AR (but not β 2 -AR) stimulation. In the AKAP −/− mice, noncaveolin-associated α 1C was phosphorylated. 25 These findings contradict an earlier observation that only β 2 -AR is associated with caveolin-3 and Ca V 1.2; disruption of caveolae fully eliminated the β-AR regulation of Cav1.2 via β2-AR but not via β 1 -AR 177 . The 2 works used different assays for the final effect of the β-AR stimulation, phosphorylation of Ser1928, 25 or the increase in I Ca , 177 which could partially account for the discrepant conclusions on the type of β-AR involved.
Even more strikingly, a full knockout of AKAP7 in mice, and even a double knockout of both AKAP5 and AKAP7, did not impair the β-AR regulation of Ca V 1.2, the phosphorylation of phospholamban and Ca V 1.2 itself on Ser1928, or the association of PKA-RII with Ca V 1.2 24 ( Table 1 ). The authors did not detect compensation by several known AKAPs, but proposed that, in mice, an unidentified AKAP anchors PKA to the vicinity of Ca V 1.2 and phospholamban. 24 It would be interesting to test whether PKA association with Cav1.2 is affected by AKAP5-D36 (which lacks PKA-R binding site, does not affect its expression, and retains functional binding sites of other regulatory proteins). 186 Using AKAP5-D36 will most likely eliminate compensation by other AKAPs and will allow scrutinizing its role in this signaling cascade. In all, the recent studies with transgenic mice reveal an additional layer of complexity of Ca V 1.2 regulation in the β-AR cascade, and to date do not support an essential role for AKAP5 or AKAP7 for the β-AR and PKA-induced enhancement of Ca V 1.2 activity in the heart.
Another protein that was proposed to take part in the enhancing effect of PKA on L-VDCC is Ahnak, a 700-kDa protein that binds Ca V β. This interaction is reduced when Ahnak is phosphorylated by PKA. Application of an unphosphorylated mutated (Ile5326Thr) Ahnak fragment to native cardiomyocytes enhanced L-VDCC current by 60%. 20 , 187 Haase 20 proposed that PKA-catalyzed phosphorylation of Ahnak itself, or together with Ca V β, releases the inhibitory control imposed by Ahnak and allows Ca V β to interact with α 1C . However, followup studies in Ahnak-deficient mice revealed that the responsiveness of the isolated transgenic hearts was similar to WT. Thus, Ahnak is not essential for the β-adrenergic stimulation of L-VDCC, but it may play a modulatory role. 188 
Concluding Remarks and Perspectives
The textbook description of Ca V 1.2 regulation by β-ARs in the heart involves activation of cAMP, PKA, and eventually an enhancement of Ca V 1.2 current by phosphorylation of the channel's subunits. Latest studies overturned previously accepted mechanisms and revealed unexpected complexities. Several points remain certain: much or all of the β-AR regulation of Ca V 1.2 in the heart is mediated by PKA; phosphorylation (probably not by PKA alone) and dephosphorylation play important roles in the regulation of intrinsic basal activity of the channel; phosphorylation of a cellular target by PKA must be a major event in channel regulation because β-AR effects are strongly attenuated by PKA inhibitors and enhanced by inhibitors of protein phosphatases. The target is strongly believed to be 1 or 2 of the channel subunits; however, the identity of the phosphorylation sites remains uncertain; phosphorylation of a missing link protein has not been excluded.
Biochemical and cell biology studies had unequivocally established Ser1928, located in the dCT of α 1C , as a major amino acid residue phosphorylated by PKA in the full-length, nontruncated α 1C . Numerous studies indicate that Ser1928 is a plausible candidate for coordination of action of protein kinases and phosphatases at least in the regulation of basal channel activity. However, it seems to play no role in mediating the β-AR-induced enhancement of Ca 2+ influx. The meaning and the function of the pronounced increase in phosphorylation of Ser1928 during the fight-or-flight β-adrenergic response remains an open question. Similarly, Ca V β subunit is an excellent PKA substrate and has been repeatedly implicated in the β-AR regulation of Ca V 1.2; but these concepts have been overturned by studies in transgenic animals and cardiomyocytes. We do not know whether Ca V β subunits participate in any way in the β-AR regulation.
The dCT, produced by the post-translational proteolytic cleavage of α 1C , has a dramatic influence on channel activity and on β-AR regulation of Ca V 1.2. Therefore, it is important to identify the protease that cleaves α 1C in the heart, and to estimate the extent and the regulation of channel proteolysis at the dCT in native heart, using scrupulous preparative protocols and new site-specific antibodies. It is important to examine whether prevention of the proteolytic cleavage in vivo, for example, by a mutation in the cleavage site in α 1C , would eliminate the β-AR regulation of Ca V 1.2.
The newly proposed molecular mechanism 42 that involves an intricate coordination of channel activity by its truncated dCT and the phosphorylation of Ser1700 and Thr1704 of α 1C by PKA is supported by recent results from Catterall laboratory suggesting that transgenic mice with the double mutation of Ser1700 and Thr1704 in α 1C show reduced exercise tolerance, reduced I Ca and expression level of α 1C , and a markedly attenuated magnitude and agonist sensitivity of β-AR-induced potentiation of I Ca (W.A. Catterall, personal communication). Yet, part of the β-AR regulation seems to persist suggesting an even more complex mechanism.
It is usually assumed that all the effects of PKA-CS are mediated by phosphorylation of target residues in Ca V 1.2, but other possibilities such as a direct interaction have not been ruled out. Hypothetically, PKA may modulate Ca V 1.2 by a direct interaction or via an AKAP but in a phosphorylationindependent manner. There are many examples in different signaling pathways, including those regulating VDCCs. The phosphatase calcineurin has been shown to regulate Ca V 1.2 by a direct interaction 189 ; CaMKII is activated after direct binding to Ca V 2.1 channels 190 ; AKAP5 directly interacts with several cytosolic segments of α 1C and was hypothesized to regulate the channel's function. 15 Extensive use of specific phosphorylation and protein interaction inhibitors is a powerful and discriminatory approach to address these options.
We now begin to understand the complexity of the βAR-PKA-Ca v pathway, which includes a large and intricate signaling complex of interacting proteins, many of which may affect the performance of the pathway. Experiments in transgenic mice may soon provide definite answers as to the role of unique phosphorylated amino acids proposed to mediate the regulation. In contrast, when addressing the roles of auxiliary proteins, compensation may compromise the insights from full-protein knockout approach. This could be the case with Ahnak, AKAP5, and AKAP7, and potentially other proteins that have not yet been sufficiently explored. Multiple and inducible knockouts may help to overcome compensation. We further propose that, within the βAR-PKA-Ca v pathway, there may be several subpathways that compensate each other when one of them is rendered nonfunctional. Such redundancy would safeguard the highly important β-AR regulation of heartbeat. Thus, the possibility remains that Ca V β, Ahnak, AKAP5, and AKAP7 are key players in different subpathways, or they carry out modulatory functions in the yet unidentified main pathway.
